Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide

Etoposide is commonly used in a variety of malignancies. A well known but rare toxicity are hypersensitivity reactions, usually manifested by chest discomfort, dyspnoea, bronchospasm and hypotension. We report the details of a patient who developed hypersensitivity reactions to intravenous etoposide...

Descripción completa

Detalles Bibliográficos
Autores principales: Siderov, J, Prasad, P, De Boer, R, Desai, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746527/
https://www.ncbi.nlm.nih.gov/pubmed/11857004
http://dx.doi.org/10.1038/sj.bjc.6600003
_version_ 1782172042855972864
author Siderov, J
Prasad, P
De Boer, R
Desai, J
author_facet Siderov, J
Prasad, P
De Boer, R
Desai, J
author_sort Siderov, J
collection PubMed
description Etoposide is commonly used in a variety of malignancies. A well known but rare toxicity are hypersensitivity reactions, usually manifested by chest discomfort, dyspnoea, bronchospasm and hypotension. We report the details of a patient who developed hypersensitivity reactions to intravenous etoposide, but subsequently tolerated the administration of intravenous etoposide phosphate with no sequalae. British Journal of Cancer (2002) 86, 12–13. DOI: 10.1038/sj/bjc/6600003 www.bjcancer.com © 2002 The Cancer Research Campaign
format Text
id pubmed-2746527
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-27465272009-09-18 Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide Siderov, J Prasad, P De Boer, R Desai, J Br J Cancer Clinical Etoposide is commonly used in a variety of malignancies. A well known but rare toxicity are hypersensitivity reactions, usually manifested by chest discomfort, dyspnoea, bronchospasm and hypotension. We report the details of a patient who developed hypersensitivity reactions to intravenous etoposide, but subsequently tolerated the administration of intravenous etoposide phosphate with no sequalae. British Journal of Cancer (2002) 86, 12–13. DOI: 10.1038/sj/bjc/6600003 www.bjcancer.com © 2002 The Cancer Research Campaign Nature Publishing Group 2002-01-07 /pmc/articles/PMC2746527/ /pubmed/11857004 http://dx.doi.org/10.1038/sj.bjc.6600003 Text en Copyright © 2002 The Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical
Siderov, J
Prasad, P
De Boer, R
Desai, J
Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
title Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
title_full Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
title_fullStr Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
title_full_unstemmed Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
title_short Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
title_sort safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746527/
https://www.ncbi.nlm.nih.gov/pubmed/11857004
http://dx.doi.org/10.1038/sj.bjc.6600003
work_keys_str_mv AT siderovj safeadministrationofetoposidephosphateafterhypersensitivityreactiontointravenousetoposide
AT prasadp safeadministrationofetoposidephosphateafterhypersensitivityreactiontointravenousetoposide
AT deboerr safeadministrationofetoposidephosphateafterhypersensitivityreactiontointravenousetoposide
AT desaij safeadministrationofetoposidephosphateafterhypersensitivityreactiontointravenousetoposide

Ejemplares similares